Who is sponsoring NCT05704270?

NCT05704270 is sponsored by Beijing Anzhen Hospital.

What drugs are being tested in NCT05704270?

Interventions in NCT05704270: Multi-domain adaptive cognitive training, Basic cognitive training with no difficulty change.

What condition does NCT05704270 study?

NCT05704270 studies Mild Cognitive Impairment, Hypertension.

Is NCT05704270 still recruiting?

NCT05704270 is currently status unknown. Last updated 30 January 2023.

Last reviewed 2023-01-30 · How we verify

NCT05704270

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Computerized Cognitive Training to Protect Cognitive Function Among Hypertension Patients

Status unknown NA Last updated 30 January 2023

What this trial tests

NA trial testing Multi-domain adaptive cognitive training in Mild Cognitive Impairment in 200 participants. Status unknown.

Timeline

1 February 2023

Primary endpoint
31 December 2024

30 March 2025

Quick facts

Lead sponsor	Beijing Anzhen Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	200
Start date	1 February 2023
Primary completion	31 December 2024
Estimated completion	30 March 2025
Sites	2 locations across China

Drugs / interventions tested

Multi-domain adaptive cognitive training
Basic cognitive training with no difficulty change

Conditions studied

Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →
Hypertension — all drugs for Hypertension →

Sponsor

Beijing Anzhen Hospital

Who can join

60 and older, any sex, with Mild Cognitive Impairment or Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hypertension is an risk factor for cognitive impairment. The primary objective of this study is to evaluate the efficacy of 12-week computerized cognitive training in people with hypertension and mild cognitive impairment. The researchers will further investigate the long-term effects of cognitive training by prolonging the intervention for 24 weeks among a randomly selected sub-group.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Digital computerised cognitive training for preventing cognitive decline among hypertensive patients: a study protocol for a multicentre randomised controlled trial (DELIGHT trial).
Kong Y, Guo QH, Zhou L, He L, et al · · 2024 · PMID 38423771 · DOI 10.1136/bmjopen-2023-079305

Verify or expand the search:

Other recruiting trials for Mild Cognitive Impairment

Currently open trials in the same condition.

NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
NCT07318038 — The Use of Rhythmic Light Therapy in Mild Cognitive Impairment · NA · recruiting

Other Beijing Anzhen Hospital trials

Trials by the same sponsor.

NCT07521488 — LLM-Based Intelligent Health Management Assistant in Life-Cycle Health Management of Cardiac Surgery Patients · NA · not yet recruiting
NCT07470814 — Multidisciplinary Collaborative Care System for Acute Myocardial Infarction Complicated With Cardiogenic Shock · not yet recruiting
NCT07444372 — Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation · NA · not yet recruiting
NCT07256197 — PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis · Phase 3 · not yet recruiting
NCT07485101 — Glycemic Targets During CPB in Elderly Diabetes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05704270 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Beijing Anzhen Hospital
Last refreshed: 30 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05704270.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing